Vast majority of ADC manufacturing outsourced, report finds #pharmaceutical #manufacturing #process

Posted On Jul 27 2017 by

#bsp pharma # Vast majority of ADC manufacturing outsourced, report finds By Zachary Brennan+ Zachary Brennan 22-Aug-2014 2014-08-22T00:00:00Z Last updated on 22-Aug-2014 at 11:06 GMT 2014-08-22T11:06:06Z Between 70-80% of ADC (antibody drug conjugate) manufacturing is performed by CMOs, according to a new report . In addition to the high concentration of outsourcing, there are a limited number of CMOs with the ability to develop linkers and cytotoxins. And even fewer CMOs can provide conjugation services for ADCs, according to the report released last week. CMOs cited in the report include SAFC, Piramal Healthcare, Lonza, Albany Molecular Research Institute, BSP Pharmaceuticals, …


Vast majority of ADC manufacturing outsourced, report finds #cipla #company

Posted On Jul 13 2017 by

#bsp pharma # Vast majority of ADC manufacturing outsourced, report finds By Zachary Brennan+ Zachary Brennan 22-Aug-2014 2014-08-22T00:00:00Z Last updated on 22-Aug-2014 at 11:06 GMT 2014-08-22T11:06:06Z Between 70-80% of ADC (antibody drug conjugate) manufacturing is performed by CMOs, according to a new report . In addition to the high concentration of outsourcing, there are a limited number of CMOs with the ability to develop linkers and cytotoxins. And even fewer CMOs can provide conjugation services for ADCs, according to the report released last week. CMOs cited in the report include SAFC, Piramal Healthcare, Lonza, Albany Molecular Research Institute, BSP Pharmaceuticals, …


Download vision to decision report: Pharma 2020: PwC #pharma #japan

Posted On Jul 11 2017 by

#pharmaceutical industry trends # Download the report In this report, we focus on how companies can reach 2020 in a position to benefit from more favourable conditions thereafter. The pharmaceutical industry is at a critical juncture. The tools to develop remarkable new medicines are materialising, demand for its products is increasing and the barriers to free trade are falling. But pharma also faces major economic and operational challenges, if it’s to capitalise on these opportunities and create more value for healthcare payers, providers and patients. Many of the conditions that will determine what happens in 2020 are already in place. …


Purdue Pharma issues statement on OxyContin report; L #generic #pharmaceutical #manufacturers

Posted On Jul 8 2017 by

#purdue pharmaceutical # Purdue Pharma issues statement on OxyContin report; L.A. Times responds urdue Pharma issued a statement Friday defending its best-selling painkiller, OxyContin, and criticizing a Los Angeles Times report that the medication wears off early in many patients, exposing them to increased risk of addiction. OxyContin s main selling point is that it relieves pain for 12 hours. The Times investigation found that when the effects don t last, patients can suffer excruciating symptoms of narcotic withdrawal, including intense craving for the drug. The article said that Purdue had held fast to 12-hour dosing in part for financial …


2010 Top 10 Biopharmaceutical Companies Report – Contract Pharma #shionogi #pharma

Posted On Jun 10 2017 by

#bio pharmaceutical companies # Related Features Our rules for inclusion on the Top 10 Biopharma list are as follows: you re a biopharma company if more than half of your drug revenues not royalties come from large-molecule drugs and vaccines. It s arbitrary, but it s worked pretty well for the past decade. This year, it means that Roche/Genentech has become the world s #1 biopharma, marking the first change at the top in 10 years. The rest of this year s list is consistent with the previous year s ranks, which is both a sign of the stability among …


Vast majority of ADC manufacturing outsourced, report finds #pharmaceutical #research #& #manufacturers #of #america

Posted On May 20 2017 by

#bsp pharma # Vast majority of ADC manufacturing outsourced, report finds By Zachary Brennan+ Zachary Brennan 22-Aug-2014 2014-08-22T00:00:00Z Last updated on 22-Aug-2014 at 11:06 GMT 2014-08-22T11:06:06Z Between 70-80% of ADC (antibody drug conjugate) manufacturing is performed by CMOs, according to a new report . In addition to the high concentration of outsourcing, there are a limited number of CMOs with the ability to develop linkers and cytotoxins. And even fewer CMOs can provide conjugation services for ADCs, according to the report released last week. CMOs cited in the report include SAFC, Piramal Healthcare, Lonza, Albany Molecular Research Institute, BSP Pharmaceuticals, …


Vast majority of ADC manufacturing outsourced, report finds #pharmaceutical #jobs

Posted On May 3 2017 by

#bsp pharma # Vast majority of ADC manufacturing outsourced, report finds By Zachary Brennan+ Zachary Brennan 22-Aug-2014 2014-08-22T00:00:00Z Last updated on 22-Aug-2014 at 11:06 GMT 2014-08-22T11:06:06Z Between 70-80% of ADC (antibody drug conjugate) manufacturing is performed by CMOs, according to a new report . In addition to the high concentration of outsourcing, there are a limited number of CMOs with the ability to develop linkers and cytotoxins. And even fewer CMOs can provide conjugation services for ADCs, according to the report released last week. CMOs cited in the report include SAFC, Piramal Healthcare, Lonza, Albany Molecular Research Institute, BSP Pharmaceuticals, …


Download vision to decision report: Pharma 2020: PwC #mds #pharma #services

Posted On May 1 2017 by

#pharmaceutical industry trends # Download the report In this report, we focus on how companies can reach 2020 in a position to benefit from more favourable conditions thereafter. The pharmaceutical industry is at a critical juncture. The tools to develop remarkable new medicines are materialising, demand for its products is increasing and the barriers to free trade are falling. But pharma also faces major economic and operational challenges, if it’s to capitalise on these opportunities and create more value for healthcare payers, providers and patients. Many of the conditions that will determine what happens in 2020 are already in place. …


2010 Top 10 Biopharmaceutical Companies Report – Contract Pharma #kiadis #pharma

Posted On Apr 25 2017 by

#bio pharmaceutical companies # Related Features Our rules for inclusion on the Top 10 Biopharma list are as follows: you re a biopharma company if more than half of your drug revenues not royalties come from large-molecule drugs and vaccines. It s arbitrary, but it s worked pretty well for the past decade. This year, it means that Roche/Genentech has become the world s #1 biopharma, marking the first change at the top in 10 years. The rest of this year s list is consistent with the previous year s ranks, which is both a sign of the stability among …


2010 Top 10 Biopharmaceutical Companies Report – Contract Pharma #la #pharma

Posted On Apr 15 2017 by

#bio pharmaceutical companies # Related Features Our rules for inclusion on the Top 10 Biopharma list are as follows: you re a biopharma company if more than half of your drug revenues not royalties come from large-molecule drugs and vaccines. It s arbitrary, but it s worked pretty well for the past decade. This year, it means that Roche/Genentech has become the world s #1 biopharma, marking the first change at the top in 10 years. The rest of this year s list is consistent with the previous year s ranks, which is both a sign of the stability among …